(1)
Motevalli, M. H.; Taheri, S.; Peiravian, F.; Yousefi, N. Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review. Int Pharm Acta 2019, 2, 2e10:1-6.